Literature DB >> 15352212

BDNF overexpression produces a long-term increase in myelin formation in the peripheral nervous system.

Ravi J Tolwani1, José M Cosgaya, Sushama Varma, Reza Jacob, Lydia E Kuo, Eric M Shooter.   

Abstract

The neurotrophin brain-derived neurotrophic factor (BDNF) is an endogenous regulator of the myelination process during development in the peripheral nervous system. Enhancement of myelin formation by BDNF is mediated by the neurotrophin receptor p75(NTR). Although this neurotrophin is a positive modulator of myelination during early development, the final effects of BDNF on myelin sheaths after active myelination is completed are largely unknown. Using BDNF transgenic mice, we examined the long-term effects of BDNF on myelination of the peripheral nervous system in vivo. Elevation of BDNF levels in the transgenic mice produced an increase in both the rate and extent of the myelination process. BDNF enhanced and accelerated myelin formation during early development and this increase in myelin content and thickness was maintained in adulthood. Besides enhanced myelination, BDNF also influenced axon caliber size but to a lesser extent. This lagging increase in axon caliber compared to myelin suggests that the axon size is not the only determinant of myelin thickness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15352212     DOI: 10.1002/jnr.20181

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  31 in total

Review 1.  Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination.

Authors:  Alejandro F De Nicola; Susana L Gonzalez; Florencia Labombarda; Maria Claudia González Deniselle; Laura Garay; Rachida Guennoun; Michael Schumacher
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.

Authors:  Kiren Ubhi; Chandra Inglis; Michael Mante; Christina Patrick; Anthony Adame; Brian Spencer; Edward Rockenstein; Verena May; Juergen Winkler; Eliezer Masliah
Journal:  Exp Neurol       Date:  2012-01-16       Impact factor: 5.330

3.  Neuroprotective effect of bone marrow stromal cell combination with atorvastatin in rat model of spinal cord injury.

Authors:  Fang Li; Dan Fei; Libo Sun; Sixun Zhang; Yue Yuan; Li Zhang; Kuiming Zhao; Rui Li; Yanbing Yu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Hydrogen-rich saline protects against spinal cord injury in rats.

Authors:  Chengwen Chen; Qianbo Chen; Yanfei Mao; Shengming Xu; Chunyan Xia; Xueyin Shi; John H Zhang; Hongbin Yuan; Xuejun Sun
Journal:  Neurochem Res       Date:  2010-03-31       Impact factor: 3.996

5.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Authors:  L Wang; M Chopp; A Szalad; Z Liu; M Bolz; F M Alvarez; M Lu; L Zhang; Y Cui; R L Zhang; Z G Zhang
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

6.  Adipose-Derived Stem Cells Expressing the Neurogenin-2 Promote Functional Recovery After Spinal Cord Injury in Rat.

Authors:  Linjun Tang; Xiaocheng Lu; Ronglan Zhu; Tengda Qian; Yi Tao; Kai Li; Jinyu Zheng; Penglai Zhao; Shuai Li; Xi Wang; Lixin Li
Journal:  Cell Mol Neurobiol       Date:  2015-08-18       Impact factor: 5.046

7.  Deletion of the mouse RegIIIbeta (Reg2) gene disrupts ciliary neurotrophic factor signaling and delays myelination of mouse cranial motor neurons.

Authors:  L A Tebar; S M Géranton; C Parsons-Perez; A S Fisher; R Bayne; A J H Smith; M Turmaine; S Perez-Luz; A Sheasby; C De Felipe; C Ruff; G Raivich; S P Hunt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

8.  BDNF mRNA expression is significantly upregulated in vestibular schwannomas and correlates with proliferative activity.

Authors:  Frauke Kramer; Timo Stöver; Athanasia Warnecke; Marc Diensthuber; Thomas Lenarz; Kirsten Wissel
Journal:  J Neurooncol       Date:  2009-11-25       Impact factor: 4.130

9.  Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications.

Authors:  George Bartzokis; Po H Lu; Todd A Tishler; Sophia M Fong; Bolanle Oluwadara; J Paul Finn; Danny Huang; Yvette Bordelon; Jim Mintz; Susan Perlman
Journal:  Neurochem Res       Date:  2007-05-05       Impact factor: 3.996

10.  Expression of NGF and GDNF family members and their receptors during peripheral nerve development and differentiation of Schwann cells in vitro.

Authors:  Marko Piirsoo; Anne Kaljas; Karin Tamm; Tõnis Timmusk
Journal:  Neurosci Lett       Date:  2009-11-26       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.